Peter L. Hoang - President and CEO, Director at Marker Therapeutics, Inc.

Issuer-level insider activity

Role
President and CEO, Director
Issuer ticker
MRKR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Peter L. Hoang since 12 Aug 2025

Reported holdings for Peter L. Hoang in Marker Therapeutics, Inc.

Form 4 holding President and CEO, Director

Marker Therapeutics, Inc.

Security class
Common Stock
Shares / value
483,286
Estimated value
$234,297
Report date
24 Mar 2022
Price
$0.4848
Ownership
Direct

Transaction history for Peter L. Hoang in Marker Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .